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Abstract  
Background: Patient information may assist in promoting shared decision-making, however it is imperative that the information 
presented is comprehensible and acceptable to the target audience.  
Objective: This study sought to explore the acceptability and comprehensibility of the ‘Medicines in Scotland: What’s the right 
treatment for you?’ factsheet to the general public. 
Methods: Qualitative semi-structured telephone interviews were conducted with members of the public. An interview schedule was 
developed to explore the acceptability and comprehensibility of the factsheet. Participants were recruited by a researcher who 
distributed information packs to attendees (n=70) of four community pharmacies. Interviews, (12-24 minutes duration), were audio 
recorded, transcribed verbatim and analysed using a framework approach. 
Results: Nineteen participants returned a consent form (27.1%), twelve were interviewed. Six themes were identified: formatting of 
the factsheet and interpretation; prior health knowledge and the factsheet; information contained in the factsheet; impact of the 
factsheet on behaviour; uses for the factsheet; and revisions to the factsheet.  
Conclusions: The factsheet was generally perceived as helpful and comprehensive. It was highlighted that reading the leaflet may 
generate new knowledge and may have a positive impact on behaviour.  
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INTRODUCTION 
Person-centred care, often advocated as a central tenet of 
healthcare, endeavours to ensure that individuals are 
adequately educated and supported in a manner which 
promotes informed decision-making and facilitates 
management of health.1,2 It is advised that person-centred 
care may be achieved via empowerment of patients, carers 
and communities. Empowerment may be promoted in a 
number of ways, including by providing support to patients 
to manage their health and increasing health literacy3, 
which may be defined as “…having the knowledge, skills, 
understanding and confidence to use health information, to 
be active partners in their care, and to navigate health and 
social care systems”.4  
A key aspect of a person-centred approach, and a focal 
public health strategy in the United Kingdom (UK) and 
globally2,5-8, is provision of support for shared decision-
making (also known as concordance9) and engagement in 
meaningful dialogue between patients and healthcare 
professionals.5 Concordance typically centres on the 
consultation between patients and healthcare 
professionals and “values the patient’s perspective, 
acknowledging that the patient has expertise in his or her 
body’s experience of illness and response to treatment”.10 
However, whilst concordance is perceived to be a central 
tenet of healthcare, recent evidence outlines the 
considerable variability in patient experiences.  
A systematic review of 63 articles evaluating concordance 
and patient treatment preferences, highlighted a sizeable 
variation between a patient’s preference for treatment and 
the actual treatment which was received (concordance 
value scores). The authors reported that known as 
concordance value scores ranged from 19% to 97% and 
hence, it was suggested, that there was a high degree of 
disparity in the provision of care in relation to patient’s 
preferences.11  
Patient information may occupy a critical role in facilitating 
concordance. For example, in the European Union (EU), 
pharmaceutical manufacturing companies are required to 
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include a patient information leaflet (PIL) within all 
medicines.12 The legislative directive requires that PILs 
comprise seven sections: identification of the medicine; 
therapeutic indications for the product; information which 
patients need to be aware of prior to taking the medicine; 
dosage and usual instructions for use; description of side 
effects; how to store the product; and, date on which the 
leaflet was prepared.13  
These stipulations and provisions strive to ensure that the 
patient is at the forefront of decision-making. Regulation of 
PILs is perceived to be of considerable importance since 
they are frequently used by patients as the principal source 
of information on medicines.13,14 Whilst legislative 
frameworks exist to promote patient involvement in taking 
medicines, a systematic review of 27 articles, published in 
2007 on the role and value of PILs to patients has 
highlighted the challenges faced in drafting information; 
owed to the variation in patient perspectives with regard to 
the degree of information that was required in relation to 
medicines.15 
Whilst patient information may be used as a means to 
empower individuals to take ownership of their health and 
increase health literacy16,17, this may prove to be a difficult 
feat due to the variability in quality of information 
presented. It has been suggested that creation of leaflets 
which are understandable may improve patients’ 
knowledge and also, may promote involvement in decision-
making.18,19 Thus, it is of paramount importance to ensure 
that patient information is presented in a manner which is 
clearly comprehensible and acceptable to the target 
audience.17,20 
Healthcare Improvement Scotland, a national organisation 
focused on driving improvements in the quality of health 
and social care21, has developed the ‘Medicines in Scotland: 
What’s the right treatment for you? Information for 
patients and the public’ factsheet (Supplement 1). The 
medicines factsheet was developed in response to a 
recommendation which highlighted the need for greater 
transparency on information with regard to decision-
making and medicines.22 Similarly, the Scottish Government 
Chief Medical Officer’s Annual Reports 2014-15 and 2015-
16, titled ‘Realistic Medicine’ and ‘Realising Realistic 
Medicine’ have highlighted the importance of involving 
patients in their own healthcare and promoting shared 
decision-making.5,7  
In fourteen pages, the A5 size factsheet provides 
information to support patients in informed decision-
making, specifically related to medicines (key sections are 
presented in Table 1). The factsheet was developed in 
collaboration with healthcare professionals, public 
partners, and patient support groups across NHSScotland. 
In February 2016 the draft medicines factsheet was 
distributed to a number of stakeholders in NHSScotland to 
give them the opportunity to share within their local 
networks (including public involvement groups and third 
sector organisations) for comment over a 10 week period. 
Eighty seven responses were received, of which 61% came 
from patients, public partners/representatives and 
patient/carer support groups. Various healthcare 
professionals responded, including doctors, nurses and 
pharmacists. The feedback informed the development of 
the final version of the medicines factsheet which was 
published in June 2016. The medicines factsheet was 
available electronically for viewing or download via the 
Healthcare Improvement Scotland’s website. Small 
numbers of the medicines factsheet were available as hard 
copy for dissemination at national events. 
In an effort to promote engagement, shared decision-
making and health literacy, this study sought to explore the 
acceptability and comprehensibility of the ‘Medicines in 
Scotland: What’s the right treatment for you?’ factsheet to 
members of the public. Acceptability23 will refer to 
satisfaction of the factsheet, and comprehensibility24, to 
how understandable the factsheet appears. Whilst the 
initial feedback led to the development of the revised 
edition, the developers, in consultation with university 
representatives, perceived a further need to conduct an in-
depth study on the acceptability and comprehensibility of 
the second iteration of the factsheet. The exploration will 
provide the information required to inform any additional 
revisions within subsequent editions of the factsheet.  
 
METHODS 
Design 
A pragmatic methodological approach was undertaken 
whereby semi-structured qualitative telephone interviews 
were conducted with members of the general public. 
Setting 
Four community pharmacies (one city-centre, two city 
suburbs and one rural) in the North East of Scotland. 
Ethical approval  
Ethical approval was granted by the University School of 
Pharmacy and Life Sciences Research Ethics Panel (Ref: S31) 
and NHS Health Research Authority East of England – 
Cambridgeshire and Hertfordshire Research Ethics 
Committee (16/EE/0461). Management permission for non-
commercial research was granted by NHS Grampian 
Research and Development (2016RG002).  
Table 1.  Main headings of the factsheet 
Heading 
I have an appointment with a healthcare professional to discuss a 
problem.  How will they decide if a medicine is needed for me? 
If I need a medicine, how does the healthcare professional decide 
which medicine to prescribe? 
What is a formulary? 
Can I be prescribed a medicine that’s not on my health board’s 
formulary? 
I have been given a medicine and I’m not sure how to take it.  
How can I find out how to take the medicine properly? 
I don’t think my medicine is working.  What should I do? 
I think I’m experiencing side effects from my medicine.  What 
should I do? 
I have heard patients can report side effects to medicines.  Where 
can I get more information on how to do this? 
I have medicines I no longer need.  What should I do with them? 
I am unhappy about my care.  How do I make a suggestion or give 
feedback? 
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Sampling and recruitment 
Members of the public, who attended four community 
pharmacies in the local area and presented at the 
pharmacy counter, were recruited by a researcher (KGS). 
The inclusion criteria specified that participants were aged 
18 years or over and were prescribed at least one medicine 
for long term use (specified on the basis that they had 
experienced taking medicines to a greater degree). Based 
on initial response rates (n=4, 26.7%), the researcher issued 
further recruitment packs (n=66) in an effort to satisfy the 
target sample size of 15. The research team initially 
hypothesised, based on prior research experience, that 15 
interviewees may be a suitable target in terms of 
anticipating saturation. A recruitment pack was presented 
by the researcher to all members of the public presenting 
at the pharmacy during the recruitment period. The 
recruitment pack contained a cover sheet which outlined 
the study inclusion criteria, a participant information sheet, 
consent form, demographics form (basic demographics in 
addition to information on number of prescribed 
medicines, to serve as a further inclusion screen, and 
disclosure of any reading/visual impairments), copy of the 
factsheet and a prepaid return envelope. All participants 
who returned a consent form and satisfied inclusion criteria 
were telephoned to arrange a suitable day and time for 
interview. Participants were required to read the factsheet, 
and if they wished, to make notes or highlight any areas, 
prior to the interview. As far as the researcher is aware 
non-participants were not present during the telephone 
interviews.  
Data generation 
The factsheet explained how an individual’s doctor (or 
other healthcare professional) decides what is the right 
treatment for them, whether they need a medicine and, if 
so, which medicine is prescribed. An interview schedule 
(Table 2 outlines the primary questions) was developed by 
the research team, with expertise in pharmacy, social 
studies, technology and health, and social care, and 
reviewed with one participant. No revisions were made to 
the interview schedule after conducting the review and 
thus, the pilot data were included in the main study. A 
researcher (KGS) with experience in in-depth interviewing 
conducted the interviews. Each interview was conducted 
via telephone, audio recorded and transcribed verbatim. 
Notes were taken where participants did not consent to 
being audio-recorded. Field notes were not recorded 
during interviews and transcripts were not returned for 
member-checking to interviewees.  
Data analysis 
Interview content was analysed using an inductive 
framework approach whereby codes are generated from 
the data. The approach comprises multiple steps and 
requires researchers to familiarise themselves with 
interview content, code relevant aspects of transcripts, 
develop a working analytical framework, apply the 
analytical framework to transcripts and charting of the data 
onto a framework matrix.25,26 For this study codes were 
applied to the first six transcripts by one researcher and 
subsequently, the analysis was reviewed independently 
and verified by the second researcher. Discrepancies in 
interpretation of codes were resolved via discussion. A 
preliminary framework of analysis was agreed after 
reviewing the initial six and applied to the remaining 
transcripts. This was reviewed after analysis of each 
transcript to ensure adequate coverage of themes. Data 
were subsequently grouped in Microsoft Excel to identify 
themes and sub-themes. No minor themes or diverse cases 
were identified during the analysis.  
 
RESULTS  
The data are presented in accordance with demographics 
and thereafter each theme and corresponding sub-themes.  
Demographics 
Of the 70 recruitment packs issued, nineteen participants 
returned a consent form (27.1%). Twelve participants were 
interviewed, a further five could not be contacted via the 
telephone number provided, one was unable to participate 
due to time pressures and another was withdrawn from the 
study as they were unable to complete the interview. 
Interviews ranged from 12 to 24 minutes. Participants were 
aged 36 to 85 years and the number of prescribed 
medicines ranged from 1 to 10. The majority were female 
(n=7) and did not have a visual or reading impairment 
(n=8). Seven were recruited from urban pharmacies, and 
the remainder from a suburban (n=2) or rural pharmacy 
(n=3). 
Formatting of the factsheet and interpretation 
Three sub-themes were identified from the analysis and 
included: (a) attractiveness of the factsheet; (b) contrast of 
the text within the factsheet; (c) composition of the 
factsheet (e.g. good layout; appropriate structure and use 
of examples). For example, interviewees found the 
factsheet visually appealing and believed others would be 
attracted to read it, 
"… I liked the pictures, I liked the colours, it was 
an attractive leaflet I thought so that people 
would feel attracted to read it" (Interviewee 10). 
Table 2.  Primary interview questions 
How do you feel about the patient information leaflet overall? 
Did the leaflet improve your understanding of medicines and 
treatment in anyway? 
Did you find the leaflet helpful?  
Did you learn anything new? 
Is there anything in the leaflet that you did not understand?  
Would you change the way you do anything because of what you 
have read? 
Would the leaflet impact on how you discuss your medicines 
with healthcare professionals? 
Would the leaflet impact on how you make decisions about your 
medicines? 
How do you think that the leaflet may be best used to help 
patients decide on appropriate treatments? 
Did you find the leaflet easy to understand? 
Are there any aspects of the leaflet that you think may require 
improvement? 
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Prior health knowledge and the factsheet 
One sub-theme was identified from the analysis and 
encapsulated aspects of ‘prior knowledge’. A number of 
interviewees reported that they had prior knowledge of 
health processes. This knowledge base was often attributed 
to either experience with managing a long term health 
condition and/or occupational background and related 
expertise, 
"…it just kind of confirmed you know what I 
already thought or knew" (Interviewee 6). 
Information contained in the factsheet 
Five sub-themes were identified from the analysis and 
included: (a) coverage of the factsheet (comprehensive and 
informative); (b) comprehensibility of the factsheet 
(language used and use of non-medical terminology; 
understanding information; difficulty retaining information 
due to length of factsheet); (c) the factsheet and 
knowledge (increased knowledge around healthcare and 
service delivery; generation of new knowledge; nothing 
new learned); (d) benefits of the factsheet (information 
may empower; information helpful); (e) critique of the 
factsheet (content patronising; information self-evident; 
unclear of target audience; unclear of purpose; complexity 
of factsheet; unhelpful to those without internet access; 
information unhelpful personally).  
For example, three interviewees felt that the information 
may empower those who read it providing them with an 
idea of what to expect from medicines and healthcare 
practitioners, and problem solving strategies. However, one 
interviewee reported that they found the information 
contained in the leaflet both wordy and complex, 
"I just felt it was a bit too complex for easy 
reading, I felt it was maybe a bit wordy" 
(Interviewee 9). 
Impact of the factsheet on behaviour 
Three sub-themes were identified and included: (a) 
factsheet would be unlikely to impact on behaviour (due to 
prior knowledge; pre-existing confidence); (b) factsheet 
may have a positive impact on behaviour (encourage 
discussions with healthcare professionals; understanding 
what to do in certain situations; reporting side-effects); (c) 
factsheet reinforced current behaviour. 
For example, interviewees highlighted that the factsheet 
may promote and encourage discussions with healthcare 
professionals. Accordingly, it may empower patients and 
equip them with the knowledge to question treatment, 
"…if you have got this booklet saying this is what 
you can do, this is what you can do then you 
wouldn’t be so bothered about doing it you 
know" (Interviewee 10). 
Distribution of the factsheet 
The most appropriate distribution outlet for the factsheet 
was identified as the primary sub-theme. For example, 
interviewees discussed the most appropriate distribution 
outlets for the factsheet and suggested that it may be 
useful to make leaflets available in various public places 
(libraries and electronic displays) along with general 
practices and pharmacies, 
"I would suggest, if you said to me the circulation, 
I would suggest places like local general practices 
in the whole of Scotland, libraries, hot points 
where there are medical, you know these 
Table 3.  Interviewees recommendations for additional sections/information and inclusions 
Recommendation Quote 
Inclusion of a query page "I think there could be a little more support on if you have queries about this, this or this, in other words at 
the end a summary or an index and put a sort of page of reference points" (Interviewee 5) 
Inclusion of a section on 
medicines running out 
"I suppose it doesn’t cover really long term use of medicines, sort of what to do when it runs out" 
(Interviewee 2) 
Inclusion of information on 
mental health 
"… I thought maybe the addition of people believe or feel they have a mental health issue, quite a delicate 
subject really, but it is not in here" (Interviewee 6) 
Inclusion of information on 
taking multiple medicines 
"…many of us as we grow older and the way that primary care is being run is that we are on a cocktail of 
medicines, you know it is two, three, four, five, six a day and therefore, I think there could be a little 
narrative in there that could be more helpful, the likelihood of things becoming difficult or having 
symptoms, that increases with the range of medicines you are taking" (Interviewee 5) 
Inclusion of information to 
assist patients in making 
choices 
"if you pursue something, you don’t necessarily need to take no for an answer, straight away if you really 
feel strongly enough about it" Interviewee 11 
Scope for personalisation "…so you probably would have to be generic and then perhaps with a little secondary sheet which would 
cover, which covers your particular circumstances" (Interviewee 3) 
Inclusion of a section on 
placebo effects 
"…it didn’t mention anything about placebo effects, I am not sure whether it should,  ‘cause I just think a 
lot of medicines are effective because they are a placebo, you know" (Interviewee 4) 
Opportunity for greater 
promotion of self-
care/management 
"I think the emphasis could be more equal in the sense that the pamphlet starts from the proposition that 
the medical practitioner’s will be correct, and I don’t think they are wrong, but it is not always 
necessarily the case that the patient should always follow the treatment that has been advised. I think 
that it is important that patients should understand that they have a responsibility to themselves to 
understand the risks and benefits and make a decision with the advice of their medical practitioner" 
(Interviewee 4) 
Inclusion of a section on 
how to use URLs 
"…you could give a clue to somebody, maybe an appendix that says, here is a quick way to find URLs" 
(Interviewee 4) 
Greater ethnic diversity in 
choice of images 
"… all the people in it were white and I don’t know if that should have been more of a mix" (Interviewee 8) 
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electronic medical contact points that they have 
in various public locations, I think it would be 
excellent to be able to guide people to having 
access to this book and particularly, certainly 
having a quantum [sic] of them available in 
practices, along with pharmacies and the like" 
(Interviewee 5). 
Revisions to the factsheet 
Although some interviewees did not perceive the need for 
any changes to be made to the factsheet, a number 
outlined areas which they considered may benefit from 
revision. These are presented under four sub-themes: (a) 
clarification of aspects of the factsheet (clarification of 
purpose and function; clarity of Yellow Card section); (b) 
wording of the factsheet (rewording to enhance clarity; 
title revisions); (c) presentation of information in the 
factsheet (brevity and simplicity; reduction in length; 
altering of internet URLs); (d) greater emphasis of aspects 
of the factsheet (inclusive of broad spectrum of healthcare 
professionals; greater emphasis on conducting a risk 
benefit analysis; greater emphasis on reading the 
manufacturer’s PIL). For example, a greater emphasis on 
pharmacists and nurses in addition to general practitioners 
(GPs), 
"…I don’t think there is enough, but maybe I am 
wrong, guidance to say that you may want to 
initially discuss certain issues with your 
pharmacist" (Interviewee 5). 
Recommendations for additional sections and further 
information within the factsheet 
Interviewees outlined opportunities to include a number of 
additional sections and highlighted areas where further 
information could be provided (Table 3). Due to the 
variability in responses, these are listed and not grouped 
into sub-themes. 
 
DISCUSSION 
The research explored the acceptability and 
comprehensibility of the ‘Medicines in Scotland: What’s the 
right treatment for you?’ factsheet with the general public. 
Participants’ feedback was grouped into key themes 
representing their perceptions of the information leaflet 
along with recommendations for improvement. The 
themes included: formatting of the factsheet and 
interpretation; prior health knowledge and the factsheet; 
information contained in the factsheet; impact of the 
factsheet on behaviour; uses for the factsheet; and, 
revisions to the factsheet.  
Interview schedules were reviewed by the multi-
disciplinary research team in an effort to promote 
credibility. Steps were also undertaken to ensure the rigour 
and trustworthiness of data, in terms of both collection and 
analysis e.g. using established research methods, prior 
interview experience of researcher conducting interviews.27 
The recruitment from multiple sites, comprising urban and 
non-urban community pharmacy settings, was a key 
strength of the research. Whilst the sample size was 
relatively small and will limit transferability of findings, the 
themes identified within the interviews were perceived to 
have achieved saturation, in that no new themes were 
emergent. The location (North East of Scotland) of the 
research may further affect transferability of findings.  
Another weakness of the study was that it was evident 
throughout the interviews that a number of participants 
had expert knowledge of medical conditions and the 
processes of the UK health and social care services and this 
may have impacted the results. For example, it may have 
been that those with an interest or expertise in health were 
more likely to be inclined to participate, resulting in a 
selection bias. Further, younger participants were poorly 
represented within the interviews possibly because they 
were conducted during office hours which may have 
resulted in selection bias. In addition, whilst the research 
endeavoured to understand the comprehensibility and 
acceptability of the factsheet, it may be that those with 
very low levels of literacy were not represented in the 
study since it would be unlikely that an individual who was 
unable to read would participate in the research. 
Moreover, participants were taking long term medicines 
and this may further limit the transferability of findings.  
The formatting of the factsheet was perceived by 
interviewees in this study to be an important aspect 
influencing acceptability. Factors included appropriate use 
of images, headings and layout. These findings are reflected 
in guidance published by Medicines and Healthcare 
products Regulatory Agency Committee on Safety of 
Medicines on the usability of manufacturers’ PILs whereby 
it is stipulated that the following aspects should be 
considered when developing a PIL in an effort to enhance 
readability: writing style; typeface; design and layout; 
headings; use of colour; and use of symbols and 
pictograms.13 A systematic review on the readability of PILs 
concluded that reduced font size and lack of illustrations 
were often encountered and negatively affected 
readability.28 Hence, the visual appeal of the factsheet may 
be a key factor in influencing an individual’s decision to 
select the leaflet for reading.  
Interviewees in this study highlighted that the factsheet 
may be a source of empowerment in that it may inform 
decision-making and promote discussions with healthcare 
professionals however, it should be cautioned that 
behavioural ‘intention’ does not necessarily correspond 
with an intended action.29 As suggested by John et al.30 in a 
study on patient evaluation of a factsheet, although 
patients may feel empowered after reading a factsheet to 
modify their actions, this may not have any measurable 
impact on behaviour. This phenomena, termed the 
‘intention-behaviour gap’ stipulates that whilst individuals 
may feel empowered to engage with a specific behaviour, 
they may fail to execute the behavior.29  
Whilst behavioural intention may not lead to enactment of 
a behaviour, previous research has been positive and has 
demonstrated the impact of patient information across a 
series of outcomes. For example, a systematic review on 
the use of decision aids, including booklets, highlighted that 
their use improved knowledge of treatment options, how 
informed they felt, understanding of the risks and benefits 
associated with treatment and, facilitated greater 
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involvement in decision-making. Further, they had a 
positive effect on the patient-healthcare professional 
relationship, having led to greater communication.19  
The findings highlight the value of conducting evaluative 
research on patient information to establish acceptability 
and comprehensibility to target populations. Whilst 
evaluation may prove costly, it is a critical factor in ensuring 
that patients understand and benefit from patient 
information. In accordance with user-testing protocols 
which specify receiving feedback over multiple rounds, it 
may be beneficial to conduct additional diagnostic 
qualitative research on revised versions of the factsheet.31 
Moreover, the findings of the study also highlight the 
importance of formatting the information contained within 
and impact of the factsheet and hence, these categories 
may be used as a checklist when developing patient 
information materials in the future.  
 
CONCLUSIONS 
The ‘Medicines in Scotland: What’s the right treatment for 
you?’ factsheet was generally perceived as helpful and 
comprehensive. It was highlighted that reading the leaflet 
generated new knowledge amongst some. In an effort to 
enhance acceptability and comprehensibility, the factsheet 
was revised in accordance with some of the 
recommendations and revisions outlined by participants in 
this study.  
For example, changes included: inclusion of a section for 
patients to complete on their medicines; changing of tone 
and wording in areas to ensure that the leaflet was more 
patient-centred; inclusion of more information on the 
benefits and risks of medicines; inclusion of information on 
how the leaflet may be best used. The updated version of 
the factsheet, published in March 2017, is available from 
http://www.healthcareimprovementscotland.org/our_wor
k/technologies_and_medicines/adtc_resources/medicines_
booklet.aspx. Further, the findings highlight the value of 
conducting evaluative research within the target group 
particularly with regard to appropriate development of 
patient information.  
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